The Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 2,400.6 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The Digital Breast Tomosynthesis Equipment Market growth  provides 3-dimensional imaging of the breast which helps in better detection of breast cancer. Digital breast tomosynthesis is a relatively new mammography technique that uses low-dose X-rays and computer reconstruction to create three-dimensional (3-D) images of the breasts. The technique provides better ability to find cancers hidden by overlapping tissue in traditional digital mammography and decreases chances of callbacks.

Market Overview:
Digital breast tomosynthesis equipment helps in the imaging of breasts layer by layer which provides better visualization of tissues and lesions as compared to conventional 2D mammography. It reduces masking and overlapping of tissues providing clinicians accurate information to detect breast cancer at an early stage. Digital breast tomosynthesis is gaining popularity as it provides improved cancer detection rate when used with 2D mammography.

Market key trends:
Digital breast tomosynthesis equipment market is witnessing high growth owing to increasing awareness about early breast cancer detection. 3D digital breast tomosynthesis screening helps in detecting 20-65% more invasive breast cancers compared to standard 2D mammography. It reduces unnecessary recall rates and unnecessary biopsies. With significant improvements in cancer detection capabilities, digital breast tomosynthesis is expected to replace 2D mammography and become the new standard of care in breast screening over the forecast period.

Porter’s Analysis

Threat of new entrants: The threat of new entrants in the digital breast tomosynthesis equipment market is low due to high capital investment requirement and dominance of key players.
Bargaining power of buyers: The bargaining power of buyers is moderate due to significant buyer concentration and presence of substitutes.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to lack of product differentiation and availability of substitutes.
Threat of new substitutes: Threat of new substitutes is moderate as new technologies like magnetic resonance imaging are emerging.
Competitive rivalry: Intense due to presence of major players.

SWOT Analysis

Strength: High sensitivity and specificity in breast cancer screening. Portability and lower radiation dose are major strengths.
Weakness: High equipment and installation costs. Limited availability in rural areas.
Opportunity: Growing awareness about early cancer screening. Increasing healthcare expenditure in developing nations.
Threats: Risk of over diagnosis and unnecessary biopsies. Emergence of alternative diagnostic technologies.

Key Takeaways

The global digital breast tomosynthesis equipment market is expected to witness high growth, exhibiting CAGR of 15% over the forecast period, due to increasing demand for early breast cancer detection. North America holds the largest share in the digital breast tomosynthesis equipment market owing to higher healthcare expenditure and massive awareness regarding cancer screening. Emerging nations like China and India are anticipated to offer lucrative opportunities due to increasing healthcare infrastructure and rising disposable income.

Key players operating in the digital breast tomosynthesis equipment market are Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation. Hologic and GE Healthcare collectively account for over 50% of the global market share due to their diversified product portfolio and wider geographical presence.